Research Article
Outcomes of Patients with Malignancy Admitted to the Intensive Care Units: A Prospective Study
Table 1
Patient characteristics and ICU stay.
| Patient characteristics |
| Number of patients, N | 272 |
| Age, yr. | Mean | 64.25 |
| Type of malignancy, n (%) | Lung cancer | 46 (16.9%) | Leukemia | 42 (15.4%) | Lymphoma | 37 (13.6%) | Others | 147 (54.1%) |
| Stage, n (%) | Solid and hematologic tumors other than leukemia | Low-intermediate (stages I–III) | 49 (22.8%) | High (stage IV) | 166 (77.2%) | Leukemia | Low or intermediate risk | 12 (30.8%) | High risk | 27 (69.2%) |
| Malignancy status, n (%) | Controlled | 198 (73.9%) | Uncontrolled | 70 (26.1%) |
| Aim of treatment, n (%) | Curative | 160 (60.6%) | Palliative | 104 (39.4%) |
| Reason for ICU admission, n (%) | Sepsis | 147 (54%) | Respiratory failure | 90 (33.1%) | Altered general status | 20 (74%) | Hemorrhagic shock | 15 (5.5%) |
| Mode of admission, n (%) | Through ED | 180 (66.2%) | Transfer from floor | 92 (33.8%) |
| Laboratory values, n (%) | Anemia | 226 (83.1%) | Leukopenia | 58 (21.3%) | Thrombocytopenia | 107 (39.3%) | Renal impairment | 103 (38.1%) |
| ICU complications, n (%) | Sepsis | 226 (83.1%) | Invasive fungal infection | 20 (7.4%) | ARDS | 63 (23.2%) | AKI | 152 (55.9%) | MOF | 94 (34.7%) |
| ICU care, n (%) | Mechanical ventilation | 157 (57.7%) | Vasopressor use | 185 (68%) | Antibiotic use | 266 (97.8%) | Dialysis | 45 (16.5%) |
| ICU length of stay, day | Mean | 14 | Median (range) | 7 (1–153) |
|
|
According to Rai classification. |